Delivery of antisense oligonucleotides using cholesterol-modified sense dendrimers and cationic lipids.
Chaltin P, Margineanu A, Marchand D, Van Aerschot A, Rozenski J, De Schryver F, Herrmann A, Müllen K, Juliano R, Fisher MH, Kang H, De Feyter S, Herdewijn P.
Chaltin P, et al. Among authors: herrmann a.
Bioconjug Chem. 2005 Jul-Aug;16(4):827-36. doi: 10.1021/bc050022g.
Bioconjug Chem. 2005.
PMID: 16029024
Free article.